Adult neurogenesis—the production of new neurons in the mature brain—represents a form of neural plasticity that continues throughout life in specific brain regions. This process is particularly prominent in the hippocampal formation, where neural stem cells in the subventricular zone (SVZ) and subgranular zone (SGZ) of the dentate gyrus give rise to functional granule cell neurons[1]. See also: Hippocampal Neurogenesis in Neurodegeneration. Understanding how adult neurogenesis is affected in neurodegenerative diseases provides critical insights into disease mechanisms and potential therapeutic interventions.
The discovery that the adult mammalian brain maintains the capacity to generate new neurons has fundamentally changed our understanding of brain plasticity. In neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease, adult neurogenesis is significantly impaired, contributing to cognitive decline and disease progression[2].
The subgranular zone (SGZ) of the dentate gyrus in the hippocampus is the primary neurogenic niche in the adult brain. Neural progenitor cells in this region differentiate into granule cells that integrate into the hippocampal circuitry, playing essential roles in memory formation, pattern separation, and cognitive flexibility[3].
The process of hippocampal neurogenesis involves several stages:
The subventricular zone (SVZ) along the lateral ventricles is another major neurogenic niche. New neurons generated here migrate through the rostral migratory stream to the olfactory bulb, where they become interneurons involved in odor discrimination[5].
Alzheimer's Disease profoundly affects adult neurogenesis at multiple stages of the disease process. Research using human postmortem brain tissue and animal models has revealed significant alterations in hippocampal neurogenesis[6].
Several pathological mechanisms contribute to impaired neurogenesis in Alzheimer's Disease:
Amyloid-beta pathology: Amyloid-beta plaques in the hippocampus directly impair neural stem cell proliferation and differentiation. Studies show that [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- reduces neurogenesis in the subgranular zone by promoting inflammatory responses and disrupting Wnt signaling pathways[7].
[Tau[/entities/[tau-protein[/entities/[tau-protein[/entities/[tau-protein--TEMP--/entities)--FIX-- pathology: Hyperphosphorylated tau proteins interfere with neuronal function and synaptic plasticity. Tau tangles in the neurogenic niches impair the survival of newly generated neurons and disrupt their integration into existing neural circuits[8].
Neuroinflammation: Chronic neuroinflammation characterized by elevated microglia activation and pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) suppresses neurogenesis in the hippocampus. [Microglia[/entities/[microglia[/entities/[microglia[/entities/[microglia--TEMP--/entities)--FIX-- in the neurogenic niche shift from a supportive phenotype to a neurotoxic one in Alzheimer's Disease[9].
Reduced neurotrophic support: Decreased brain-derived neurotrophic factor (BDNF) levels in the Alzheimer's Disease brain impair the survival and differentiation of new neurons. Loss of BDNF signaling contributes to the failure of neurogenic niches to regenerate lost neurons[10].
Parkinson's Disease affects adult neurogenesis in both the hippocampal and olfactory neurogenic regions. Research has demonstrated reduced hippocampal neurogenesis in Parkinson's Disease patients, contributing to the cognitive impairment and depression that often accompany motor symptoms[11].
Alpha-synuclein toxicity: Alpha-synuclein aggregates spread to neurogenic regions, where they impair neural stem cell function and reduce neurogenesis. The accumulation of Lewy bodies in the SVZ and SGZ disrupts the microenvironment necessary for neuron production[12].
Dopaminergic degeneration: The loss of dopaminergic neurons in the substantia nigra affects neurogenesis through reduced dopaminergic signaling in the hippocampus, which normally promotes neural progenitor cell proliferation[13].
The subventricular zone-olfactory bulb pathway is particularly vulnerable in Parkinson's Disease. Olfactory dysfunction often precedes motor symptoms by years, reflecting early impairment of this neurogenic niche. Reduced olfactory neurogenesis contributes to the anosmia commonly observed in Parkinson's Disease patients[14].
Huntington's Disease severely impairs adult neurogenesis in the hippocampus. Mutant [huntingtin[/entities/[huntingtin-protein[/entities/[huntingtin-protein[/entities/[huntingtin-protein--TEMP--/entities)--FIX-- protein is expressed in neural stem cells, where it disrupts multiple cellular processes[15]:
Several drug candidates aim to enhance adult neurogenesis:
Physical exercise is the most robust non-pharmacological intervention for enhancing adult neurogenesis:
Dietary approaches that support neurogenesis include caloric restriction, omega-3 fatty acid supplementation, flavonoid-rich foods, and intermittent fasting. Environmental enrichment through novel learning experiences, social engagement, and stress reduction also supports neurogenic activity.
Transplantation of neural stem cells or induced pluripotent stem cell-derived neurons represents a direct approach to replacing lost neurons. Clinical trials are underway for Parkinson's Disease and other neurodegenerative conditions, though challenges remain in achieving proper functional integration[17].
Assessing adult neurogenesis in living humans remains challenging. Current approaches include:
Neuroimaging: Advanced MRI techniques can detect changes in hippocampal volume, though they cannot directly measure neurogenesis. Diffusion tensor imaging and functional MRI provide indirect evidence of neurogenic activity.
CSF biomarkers: Neurochemical markers in cerebrospinal fluid may reflect neurogenic activity, including levels of neurogranin and brain-derived neurotrophic factor.
Postmortem analysis: The gold standard for quantifying neurogenesis, though limited by postmortem interval and tissue fixation effects. Bromodeoxyuridine (BrdU) labeling in cancer patients has provided valuable human data[18].
Research priorities include developing reliable in vivo biomarkers for neurogenesis, understanding the functional contribution of new neurons to cognition, translating preclinical findings into clinical interventions, and creating personalized approaches based on individual disease characteristics. Advances in single-cell sequencing and organoid models hold promise for elucidating the molecular mechanisms governing adult neurogenesis in neurodegenerative disease.
The study of Adult Neurogenesis In Neurodegenerative Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4(11):1313-1317. DOI:10.1038/3305
Kempermann G, Gage FH. Functional neurogenesis in the adult hippocampus. Nature. 2002;415(6875):1020-1024. DOI:10.1038/4151020a
Gage FH. Adult neurogenesis in mammals. Science. 2019;364(6443):827-828. DOI:10.1126/science.aaw5585
Sorrells SF, Paredes MF, Velez A, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555(7698):377-381. DOI:10.1038/nature25975
Lim DA, Alvarez-Buylla A. Adult neural stem cells bridge the gap between the subventricular zone and olfactory bulb. Nat Rev Neurosci. 2014;15(4):213-232. DOI:10.1038/nrn3670
Boldrini M, Fulmore CA, Tartt AN, et al. Human hippocampal neurogenesis buffers stress responses and glutamatergic dysfunction. Cell Stem Cell. 2018;23(3):387-394.e5. DOI:10.1016/j.stem.2018.08.013
Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008;132(4):645-660. DOI:10.1016/j.cell.2008.01.033
Winner B, Kohl Z, Gage FH. Adult neurogenesis and neurodegenerative disease. Nat Rev Neurosci. 2011;12(5):269-280. DOI:10.1038/nrn3034
Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: The role of breach of the blood-brain barrier and stem cells. J Neurosci Res. 2009;87(5):1017-1024. DOI:10.1002/jnr.21945
Tapia-Rojas C, Arrese AL, Soto V, et al. Adult hippocampal neurogenesis as a target of environmental enrichment in Alzheimer's disease. J Alzheimers Dis. 2019;71(2):365-384. DOI:10.3233/JAD-190372
Marxreiter F, Regner J, Glatzer M, et al. Adult neurogenesis in Parkinson's Disease. Cell Tissue Res. 2018;353(1):1-15. DOI:10.1007/s00441-017-2787-5
Braak H, Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson's disease. Adv Anat Embryol Cell Biol. 2009;201:1-119.
Höglinger GU, Rizk P, Muriel MP, et al. Dopamine depletion impairs precursor cell proliferation in Parkinson's disease. Nat Neurosci. 2004;7(7):726-735. DOI:10.1038/nn1265
Sobhani S, Dadashi A, Haeili A, et al. Olfactory dysfunction in Parkinson's disease: A review of the pathogenesis and clinical features. J Parkinsons Dis. 2021;11(3):947-956. DOI:10.3233/JPD-212563
Tattersfield AS, Croon RJ, Liu YW, et al. Neurogenesis in Huntington's disease: From pathophysiology to therapy. Neuroscience. 2022;489:1-18. DOI:10.1016/j.neuroscience.2022.02.013
Voss MW, Vivar C, Kramer AF, et al. Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci. 2013;17(10):525-544. DOI:10.1016/j.tics.2013.08.001
Lindvall O, Barker RA, Brüstle O, et al. Clinical translation of stem cell-based interventions for Parkinson's disease. Mov Disord. 2019;34(8):1105-1119. DOI:10.1002/mds.27750
Spalding KL, Bergmann O, Alkass K, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013;153(6):1219-1227. DOI:10.1016/j.cell.2013.05.002
🟡 Moderate Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 18 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |
Overall Confidence: 41%